First Time Loading...

Takeda Pharmaceutical Co Ltd
TSE:4502

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
TSE:4502
Watchlist
Price: 4 125 JPY -0.43% Market Closed
Updated: May 7, 2024

Takeda Pharmaceutical Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Takeda Pharmaceutical Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
4568
4578
4523
4519
4503

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Takeda Pharmaceutical Co Ltd
TSE:4502
Income from Continuing Operations
¥178.3B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
2%
Daiichi Sankyo Co Ltd
TSE:4568
Income from Continuing Operations
¥186.6B
CAGR 3-Years
38%
CAGR 5-Years
23%
CAGR 10-Years
6%
Otsuka Holdings Co Ltd
TSE:4578
Income from Continuing Operations
¥125.5B
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
-3%
Eisai Co Ltd
TSE:4523
Income from Continuing Operations
¥46.7B
CAGR 3-Years
-21%
CAGR 5-Years
-7%
CAGR 10-Years
1%
Chugai Pharmaceutical Co Ltd
TSE:4519
Income from Continuing Operations
¥325.5B
CAGR 3-Years
15%
CAGR 5-Years
28%
CAGR 10-Years
20%
Astellas Pharma Inc
TSE:4503
Income from Continuing Operations
¥37.3B
CAGR 3-Years
-35%
CAGR 5-Years
-29%
CAGR 10-Years
-9%

See Also

What is Takeda Pharmaceutical Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
178.3B JPY

Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Income from Continuing Operations amounts to 178.3B JPY.

What is Takeda Pharmaceutical Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
2%

Over the last year, the Income from Continuing Operations growth was -35%.